Q3 2019 Holdings
Filed 2019-11-14 | 109 holdings | $4.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $1.5B | 40,854,586 | 36.4% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $1.4B | 11,777,285 | 35.7% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $511.5M | 7,589,294 | 12.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $326.6M | 3,390,270 | 8.1% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $116.2M | 1,019,557 | 2.9% |
| Cerus Corporation(CERS) | COM | 157085101 | $55.4M | 10,749,937 | 1.4% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $36.5M | 12,725,472 | 0.9% |
| Adaptive Biotechnologies Corporation(ADPT) | COM | 00650F109 | $36.0M | 1,165,411 | 0.9% |
| Axsome Therapeutics, Inc.(AXSM) | COM | 05464T104 | $15.6M | 772,286 | 0.4% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $7.1M | 1,341,902 | 0.2% |
| Seattle Genetics, Inc. | COM | 812578102 | $4.3M | 50,057,277 | 0.1% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $2.6M | 175,000 | 0.1% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.4M | 31,976,557 | 0.1% |
| Autolus Therapeutics plc(AUTL) | SPON ADS | 05280R100 | $1.9M | 156,773 | 0.0% |
| CytomX Therapeutics, Inc.(CTMX) | COM | 23284F105 | $1.4M | 194,377 | 0.0% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $1.1M | 121,534 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $808.8K | 8,258,068 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR | 023111206 | $629.8K | 41,544,288 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $627.0K | 9,244,665 | 0.0% |
| Aquestive Therapeutics, Inc.(AQST) | COM | 03843E104 | $317.0K | 99,600 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $169.4K | 8,792,678 | 0.0% |
| Kodiak Sciences Inc.(KOD) | COM | 50015M109 | $131.5K | 9,145,116 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $127.5K | 1,415,283 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $111.3K | 6,018,104 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $101.8K | 1,307,220 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $100.8K | 1,169,278 | 0.0% |
| MyoKardia, Inc. | COM | 62857M105 | $79.1K | 1,517,237 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $72.9K | 751,927 | 0.0% |
| Tricida, Inc.(1T7) | COM | 89610F101 | $60.8K | 1,969,905 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $58.5K | 2,708,200 | 0.0% |
| IGM Biosciences, Inc.(1K0) | COM | 449585108 | $55.8K | 3,144,000 | 0.0% |
| Ra Pharmaceuticals, Inc. | COM | 74933V108 | $55.5K | 2,345,496 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $47.4K | 5,509,560 | 0.0% |
| Principia Biopharma Inc.(PRNB) | COM | 74257L108 | $46.7K | 1,654,029 | 0.0% |
| Atreca, Inc.(BCELUSD) | CL A Common | 04965G109 | $43.2K | 3,532,760 | 0.0% |
| GW Pharmaceuticals plc | ADS | 36197T103 | $42.7K | 370,845 | 0.0% |
| Zymeworks Inc. | COM | 98985W102 | $42.4K | 1,708,472 | 0.0% |
| Audentes Therapeutics, Inc.(BOLDEUR) | COM | 05070R104 | $42.3K | 1,506,438 | 0.0% |
| Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | $42.1K | $30,770,000 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $39.3K | 2,229,760 | 0.0% |
| Krystal Biotech, Inc.(KRYS) | COM | 501147102 | $35.9K | 1,034,674 | 0.0% |
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $32.2K | 11,305,679 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $29.2K | 5,707,411 | 0.0% |
| Allakos Inc.(ALLKGUSD) | COM | 01671P100 | $26.7K | 339,690 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $23.8K | 2,799,577 | 0.0% |
| Merus N.V. | COM | N5749R100 | $20.7K | 1,160,014 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $20.4K | 517,700 | 0.0% |
| UroGen Pharma Ltd.(URGN) | COM | M96088105 | $17.8K | 747,751 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | $14.7K | $15,000,000 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $14.4K | 428,120 | 0.0% |